Clinical Trial

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 8, 2022 (before its estimated December 2023 completion). Its status may not reflect the trial's current state.
Summary
This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic Cardiomyopathy at high risk of progression to overt heart failure.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-09-05; most recent amendment 2025-01-28.
Status change: Active, Not Recruiting → Completed 2025-01-28
Status change: Recruiting → Active, Not Recruiting 2022-12-07
Status change: Not Yet Recruiting → Recruiting 2019-10-14
Trial Details
NCT Number NCT04083339
Lead Sponsor Applied Therapeutics, Inc.
Conditions Diabetic Cardiomyopathies
Enrollment 675 participants
Start Date 2019-09-20
Primary Completion 2023-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2022-12-08